Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress.
Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ · Brain research · 2010
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Molecular hydrogen produced a favorable primary result in this animal study, supporting further research into its potential for alzheimer’s disease.
Hydrogen-rich saline alzheimer’s disease study 2010: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This animal study examined Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer’s disease by reduction of oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them). The abstract describes Rat model; sample size 84; hydrogen delivered as hydrogen-rich saline and injected or infused hydrogen; reported duration 14 days.
Publication: Li J, Wang C, Zhang JH, Cai JM, Cao YP, Sun XJ, Brain research, 2010.
What the researchers studied
The levels of MDA, IL-6 and TNF-alpha were assessed by biochemical and ELISA analysis.
What effects did molecular hydrogen have?
Observed hydrogen effects: This study is to examine if hydrogen-rich saline reduced amyloid beta (Abeta) induced neural inflammation, and learning and memory deficits in a rat model. LTP were used to detect the electrophysiology changes, HNE and GFAP immunohistochemistry were used to assess the oxidative stress (an imbalance in which reactive molecules exceed the body’s ability to control them) and glial cell activation.
Why these findings matter
The result supports the biological and therapeutic potential of hydrogen-rich saline for alzheimer’s disease. It shows that hydrogen affected meaningful outcomes in an animal model, but it does not prove that the same benefit will occur in people.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials. The reported sample size was 84.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Rat model
- Sample size: 84
- Hydrogen method: Hydrogen-rich saline
- Dose or treatment amount: 330g
- Treatment duration: 14 days
Limitations and safety
Important limitations: Preclinical animal findings may not translate directly to human outcomes. The intervention or follow-up period appears relatively short.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.